The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 356:312-313 January 18, 2007 Number 3
NextNext

Amantadine-Resistant Influenza A (H3N2) Virus in Japan, 2005–2006

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
To the Editor: Strains of influenza A (H3N2) virus with a specific mutation (Ser31Asn) have recently shown a dramatic increase in resistance to amantadine in communities in Asia and North America. This resistance in 70 to 90% of strains has occurred despite the absence of sustained selective drug pressure.1,2 We conducted a multicenter study to assess the prevalence of such resistance during the 2005–2006 influenza season in Japan. The study included molecular analysis of the hemagglutinin gene of resistant and sensitive influenza A (H3N2) viruses.

We examined a total of 415 isolates of influenza A virus, sampled from November 2005 . . . [Full Text of this Article]


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.